Literature DB >> 21900826

Sex and race differences in the prevalence of fatty liver disease as measured by computed tomography liver attenuation in European American and African American participants of the NHLBI family heart study.

Kari E North1, Mariaelisa Graff, Nora Franceschini, Alexander P Reiner, Mary F Feitosa, John Jeffrey Carr, Penny Gordon-Larsen, Mary K Wojczynski, Ingrid B Borecki.   

Abstract

BACKGROUND AND AIMS: Liver attenuation (LA) [Hounsfield Units (HU)] by computed tomography is a validated quantitative measure that is inversely related to liver fat burden. We examined race and sex differences on the distribution of LA [one of the first stages of fatty liver disease (FLD)] and the predictors of these mean differences in European American (EA) and African American (AA) participants of the Family Heart Study.
MATERIALS AND METHODS: A total of 1242 (1064 EA, 178 AA) and 1477 (1150 EA, 327 AA) men and women, respectively, underwent computed tomography examination from which LA and abdominal adipose volume were measured. LA (adjusted for phantom and field center) was the dependent variable in linear mixed models (to control for family relatedness) that tested for mean differences by race and by sex. Independent explanatory variables included age, BMI, visceral adipose tissue volume (VAT), subcutaneous adipose tissue volume, alcohol consumption, triglyceride, HDL-cholesterol, and insulin resistance.
RESULTS: Mean LA varied significantly by sex, [(men) 57.76±10.03 HU and (women) 60.03±10.91 HU, P=0.0002], but not by race. Higher LA was associated with older age, whereas higher values of VAT, triglycerides, and insulin resistance were associated with lower LA in men and women. In contrast, alcohol consumption and BMI were associated with lower LA only among men. In analyses stratified by race, LA was associated with alcohol consumption, VAT, and insulin resistance in both EA and AA and with age, BMI, and HDL-cholesterol in EA participants only.
CONCLUSIONS: Our study findings confirm that there are important sex differences and race by sex interaction effects on the distribution of LA, the prevalence of FLD, and on the influence of metabolic risk factors on LA and FLD.

Entities:  

Mesh:

Year:  2012        PMID: 21900826      PMCID: PMC3233637          DOI: 10.1097/MEG.0b013e32834a94fb

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  36 in total

1.  PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease.

Authors:  Elizabeth K Speliotes; Johannah L Butler; Cameron D Palmer; Benjamin F Voight; Joel N Hirschhorn
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

2.  Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study.

Authors:  Elizabeth K Speliotes; Joseph M Massaro; Udo Hoffmann; Ramachandran S Vasan; James B Meigs; Dushyant V Sahani; Joel N Hirschhorn; Christopher J O'Donnell; Caroline S Fox
Journal:  Hepatology       Date:  2010-06       Impact factor: 17.425

3.  Comparison of CT methods for determining the fat content of the liver.

Authors:  Yoshihisa Kodama; Chaan S Ng; Tsung T Wu; Gregory D Ayers; Steven A Curley; Eddie K Abdalla; Jean Nicolas Vauthey; Chusilp Charnsangavej
Journal:  AJR Am J Roentgenol       Date:  2007-05       Impact factor: 3.959

4.  Fatty liver is independently associated with alterations in circulating HDL2 and HDL3 subfractions.

Authors:  Konstantinos Kantartzis; Kilian Rittig; Alexander Cegan; Jürgen Machann; Fritz Schick; Bernd Balletshofer; Andreas Fritsche; Erwin Schleicher; Hans-Ulrich Häring; Norbert Stefan
Journal:  Diabetes Care       Date:  2007-11-13       Impact factor: 19.112

5.  Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.

Authors:  D R Matthews; J P Hosker; A S Rudenski; B A Naylor; D F Treacher; R C Turner
Journal:  Diabetologia       Date:  1985-07       Impact factor: 10.122

6.  Liver fat and lipid oxidation in humans.

Authors:  Anna Kotronen; Anneli Seppälä-Lindroos; Satu Vehkavaara; Robert Bergholm; Keith N Frayn; Barbara A Fielding; Hannele Yki-Järvinen
Journal:  Liver Int       Date:  2009-07-07       Impact factor: 5.828

7.  Ethnic differences in hepatic steatosis: an insulin resistance paradox?

Authors:  Richard Guerrero; Gloria L Vega; Scott M Grundy; Jeffrey D Browning
Journal:  Hepatology       Date:  2009-03       Impact factor: 17.425

8.  Correlates and heritability of nonalcoholic fatty liver disease in a minority cohort.

Authors:  Lynne E Wagenknecht; Ann L Scherzinger; Elizabeth R Stamm; Anthony J G Hanley; Jill M Norris; Yii-Der I Chen; Michael Bryer-Ash; Steven M Haffner; Jerome I Rotter
Journal:  Obesity (Silver Spring)       Date:  2009-02-19       Impact factor: 5.002

9.  Noninvasive estimation of hepatic steatosis using plain CT vs. chemical-shift MR imaging: significance for living donors.

Authors:  Kengo Yoshimitsu; Yousuke Kuroda; Makoto Nakamuta; Akinobu Taketomi; Hiroyuki Irie; Tsuyoshi Tajima; Masakazu Hirakawa; Kousei Ishigami; Yasuhiro Ushijima; Tomomi Yamada; Hiroshi Honda
Journal:  J Magn Reson Imaging       Date:  2008-09       Impact factor: 4.813

10.  Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease.

Authors:  Stefano Romeo; Julia Kozlitina; Chao Xing; Alexander Pertsemlidis; David Cox; Len A Pennacchio; Eric Boerwinkle; Jonathan C Cohen; Helen H Hobbs
Journal:  Nat Genet       Date:  2008-09-25       Impact factor: 38.330

View more
  12 in total

1.  Fully automatic liver attenuation estimation combing CNN segmentation and morphological operations.

Authors:  Yuankai Huo; James G Terry; Jiachen Wang; Sangeeta Nair; Thomas A Lasko; Barry I Freedman; J Jeffery Carr; Bennett A Landman
Journal:  Med Phys       Date:  2019-07-05       Impact factor: 4.071

2.  Racial/ethnic differences in hepatic steatosis in a population-based cohort of post-menopausal women: the Michigan Study of Women's Health Across the Nation.

Authors:  C Kim; S D Harlow; C A Karvonen-Gutierrez; J F Randolph; M Helmuth; S Kong; B Nan; R Carlos
Journal:  Diabet Med       Date:  2013-06-07       Impact factor: 4.359

3.  Decreased Mitochondrial Dynamics Is Associated with Insulin Resistance, Metabolic Rate, and Fitness in African Americans.

Authors:  John J Dubé; Michael L Collyer; Sara Trant; Frederico G S Toledo; Bret H Goodpaster; Erin E Kershaw; James P DeLany
Journal:  J Clin Endocrinol Metab       Date:  2020-04-01       Impact factor: 5.958

Review 4.  Nonalcoholic fatty liver disease and aging: epidemiology to management.

Authors:  Marco Bertolotti; Amedeo Lonardo; Chiara Mussi; Enrica Baldelli; Elisa Pellegrini; Stefano Ballestri; Dante Romagnoli; Paola Loria
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

5.  Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease.

Authors:  Nima Motamed; Masoudreza Sohrabi; Hossein Ajdarkosh; Gholamreza Hemmasi; Mansooreh Maadi; Fatemeh Sima Sayeedian; Reza Pirzad; Khadijeh Abedi; Sivil Aghapour; Mojtaba Fallahnezhad; Farhad Zamani
Journal:  World J Gastroenterol       Date:  2016-03-14       Impact factor: 5.742

6.  Skeletal muscle and organ masses differ in overweight adults with type 2 diabetes.

Authors:  Lance E Davidson; David E Kelley; Stanley Heshka; John Thornton; F Xavier Pi-Sunyer; Lawrence Boxt; Ashok Balasubramanyam; Dympna Gallagher
Journal:  J Appl Physiol (1985)       Date:  2014-06-19

7.  Racial and Ethnic Disparities in Nonalcoholic Fatty Liver Disease Prevalence, Severity, and Outcomes in the United States: A Systematic Review and Meta-analysis.

Authors:  Nicole E Rich; Stefany Oji; Arjmand R Mufti; Jeffrey D Browning; Neehar D Parikh; Mobolaji Odewole; Helen Mayo; Amit G Singal
Journal:  Clin Gastroenterol Hepatol       Date:  2017-09-29       Impact factor: 11.382

8.  PNPLA3 gene-by-visceral adipose tissue volume interaction and the pathogenesis of fatty liver disease: the NHLBI family heart study.

Authors:  M Graff; K E North; N Franceschini; A P Reiner; M Feitosa; J J Carr; P Gordon-Larsen; M K Wojczynski; I B Borecki
Journal:  Int J Obes (Lond)       Date:  2012-05-01       Impact factor: 5.095

9.  Metabolic impact of sex chromosomes.

Authors:  Jenny C Link; Xuqi Chen; Arthur P Arnold; Karen Reue
Journal:  Adipocyte       Date:  2013-04-01       Impact factor: 4.534

10.  Waist-to-height ratio is more closely associated with alanine aminotransferase levels than body mass index and waist circumference among population-based children: a cross-sectional study in Japan.

Authors:  Hirotaka Ochiai; Takako Shirasawa; Rimei Nishimura; Hinako Nanri; Tadahiro Ohtsu; Hiromi Hoshino; Naoko Tajima; Akatsuki Kokaze
Journal:  BMC Pediatr       Date:  2015-05-17       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.